Filing Details
- Accession Number:
- 0001127602-12-014017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-17 13:00:00
- Reporting Period:
- 2012-04-13
- Filing Date:
- 2012-04-17
- Accepted Time:
- 2012-04-17 16:28:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242992 | P Timothy Clackson | C/O Ariad Pharmaceuticals Inc 26 Landsdowne Street Cambridge MA 02139 | President, R&D, Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-04-13 | 31,600 | $14.83 | 240,889 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-04-17 | 7,111 | $15.00 | 233,778 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.69 to $15.24, inclusive. The reporting person undertakes to provide to ARIAD Pharmaceuticals, Inc. ("ARIAD"), any security holder of ARIAD, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
